Recognizing Refractory Myasthenia Gravis:
An in-depth look at a rare disease Myasthenia gravis (MG) is a rare autoimmune disorder of the neuromuscular junction, characterized by muscle fatigability. Patients often initially present with ocular symptoms, but in most cases the disease spreads beyond the eye muscles to more generalized involve...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Basel
S. Karger
2018
|
| Schriftenreihe: | Fast facts
|
| Online-Zugang: | DE-19 URL des Erstveröffentlichers |
| Zusammenfassung: | An in-depth look at a rare disease Myasthenia gravis (MG) is a rare autoimmune disorder of the neuromuscular junction, characterized by muscle fatigability. Patients often initially present with ocular symptoms, but in most cases the disease spreads beyond the eye muscles to more generalized involvement of bulbar, facial, neck, proximal limb and respiratory muscles. With adequate treatment, most patients with MG are able to live productive lives with few or no symptoms, but a distinct subset of patients do not respond to conventional treatment. With new treatment options on the horizon, it is important that these patients are identified. 'Fast Facts: Recognizing Refractory Myasthenia Gravis' takes an in-depth look at: • the immune-mediated nature of MG • classification of MG by disease type and severity, and antibody status • clinical presentation and diagnostic work-up • conventional management options • how patients with treatment-refractory MG present • the assessment tools that can be used to identify non-responders. This informative resource will be of value to neurologists, neurology trainees and ophthalmologists caring for patients with this rare disease, as well as patients with MG who wish to have a deeper dialog with their doctor or patient group. Contents: • Definition and epidemiology • Pathophysiology and classification • Diagnosis and management: an overview • Assessment of disease severity and treatment response |
| Beschreibung: | 1 Online-Ressource |
| ISBN: | 9781910797549 |
| DOI: | 10.1159/isbn.978-1-910797-54-9 |
Internformat
MARC
| LEADER | 00000nam a22000001c 4500 | ||
|---|---|---|---|
| 001 | BV047811887 | ||
| 003 | DE-604 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 220202s2018 xx o|||| 00||| eng d | ||
| 020 | |a 9781910797549 |9 978-1-910797-54-9 | ||
| 024 | 7 | |a 10.1159/isbn.978-1-910797-54-9 |2 doi | |
| 035 | |a (OCoLC)1296342634 | ||
| 035 | |a (DE-599)HEB486212157 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-384 | ||
| 100 | 1 | |a Silvestri, Nicholas J. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Recognizing Refractory Myasthenia Gravis |c Nicholas J. Silvestri, Jacqueline A. Palace |
| 264 | 1 | |a Basel |b S. Karger |c 2018 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Fast facts | |
| 520 | 3 | |a An in-depth look at a rare disease Myasthenia gravis (MG) is a rare autoimmune disorder of the neuromuscular junction, characterized by muscle fatigability. Patients often initially present with ocular symptoms, but in most cases the disease spreads beyond the eye muscles to more generalized involvement of bulbar, facial, neck, proximal limb and respiratory muscles. With adequate treatment, most patients with MG are able to live productive lives with few or no symptoms, but a distinct subset of patients do not respond to conventional treatment. With new treatment options on the horizon, it is important that these patients are identified. 'Fast Facts: Recognizing Refractory Myasthenia Gravis' takes an in-depth look at: • the immune-mediated nature of MG • classification of MG by disease type and severity, and antibody status • clinical presentation and diagnostic work-up • conventional management options • how patients with treatment-refractory MG present • the assessment tools that can be used to identify non-responders. This informative resource will be of value to neurologists, neurology trainees and ophthalmologists caring for patients with this rare disease, as well as patients with MG who wish to have a deeper dialog with their doctor or patient group. Contents: • Definition and epidemiology • Pathophysiology and classification • Diagnosis and management: an overview • Assessment of disease severity and treatment response | |
| 700 | 1 | |a Palace, Jacqueline A. |e Verfasser |4 aut | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-1-910797-53-2 |
| 856 | 4 | 0 | |u https://doi.org/10.1159/isbn.978-1-910797-54-9 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-25-KFF | ||
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-033195381 | |
| 966 | e | |u https://doi.org/10.1159/isbn.978-1-910797-54-9 |l DE-19 |p ZDB-25-KFF |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1818858712504205312 |
|---|---|
| adam_text | |
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Silvestri, Nicholas J. Palace, Jacqueline A. |
| author_facet | Silvestri, Nicholas J. Palace, Jacqueline A. |
| author_role | aut aut |
| author_sort | Silvestri, Nicholas J. |
| author_variant | n j s nj njs j a p ja jap |
| building | Verbundindex |
| bvnumber | BV047811887 |
| collection | ZDB-25-KFF |
| ctrlnum | (OCoLC)1296342634 (DE-599)HEB486212157 |
| doi_str_mv | 10.1159/isbn.978-1-910797-54-9 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a22000001c 4500</leader><controlfield tag="001">BV047811887</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">220202s2018 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781910797549</subfield><subfield code="9">978-1-910797-54-9</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1159/isbn.978-1-910797-54-9</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1296342634</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)HEB486212157</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-384</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Silvestri, Nicholas J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Recognizing Refractory Myasthenia Gravis</subfield><subfield code="c">Nicholas J. Silvestri, Jacqueline A. Palace</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel</subfield><subfield code="b">S. Karger</subfield><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Fast facts</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">An in-depth look at a rare disease Myasthenia gravis (MG) is a rare autoimmune disorder of the neuromuscular junction, characterized by muscle fatigability. Patients often initially present with ocular symptoms, but in most cases the disease spreads beyond the eye muscles to more generalized involvement of bulbar, facial, neck, proximal limb and respiratory muscles. With adequate treatment, most patients with MG are able to live productive lives with few or no symptoms, but a distinct subset of patients do not respond to conventional treatment. With new treatment options on the horizon, it is important that these patients are identified. 'Fast Facts: Recognizing Refractory Myasthenia Gravis' takes an in-depth look at: • the immune-mediated nature of MG • classification of MG by disease type and severity, and antibody status • clinical presentation and diagnostic work-up • conventional management options • how patients with treatment-refractory MG present • the assessment tools that can be used to identify non-responders. This informative resource will be of value to neurologists, neurology trainees and ophthalmologists caring for patients with this rare disease, as well as patients with MG who wish to have a deeper dialog with their doctor or patient group. Contents: • Definition and epidemiology • Pathophysiology and classification • Diagnosis and management: an overview • Assessment of disease severity and treatment response</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Palace, Jacqueline A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-1-910797-53-2</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1159/isbn.978-1-910797-54-9</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-25-KFF</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033195381</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1159/isbn.978-1-910797-54-9</subfield><subfield code="l">DE-19</subfield><subfield code="p">ZDB-25-KFF</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV047811887 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T19:05:25Z |
| indexdate | 2024-12-19T09:00:38Z |
| institution | BVB |
| isbn | 9781910797549 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033195381 |
| oclc_num | 1296342634 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-384 |
| owner_facet | DE-19 DE-BY-UBM DE-384 |
| physical | 1 Online-Ressource |
| psigel | ZDB-25-KFF |
| publishDate | 2018 |
| publishDateSearch | 2018 |
| publishDateSort | 2018 |
| publisher | S. Karger |
| record_format | marc |
| series2 | Fast facts |
| spelling | Silvestri, Nicholas J. Verfasser aut Recognizing Refractory Myasthenia Gravis Nicholas J. Silvestri, Jacqueline A. Palace Basel S. Karger 2018 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Fast facts An in-depth look at a rare disease Myasthenia gravis (MG) is a rare autoimmune disorder of the neuromuscular junction, characterized by muscle fatigability. Patients often initially present with ocular symptoms, but in most cases the disease spreads beyond the eye muscles to more generalized involvement of bulbar, facial, neck, proximal limb and respiratory muscles. With adequate treatment, most patients with MG are able to live productive lives with few or no symptoms, but a distinct subset of patients do not respond to conventional treatment. With new treatment options on the horizon, it is important that these patients are identified. 'Fast Facts: Recognizing Refractory Myasthenia Gravis' takes an in-depth look at: • the immune-mediated nature of MG • classification of MG by disease type and severity, and antibody status • clinical presentation and diagnostic work-up • conventional management options • how patients with treatment-refractory MG present • the assessment tools that can be used to identify non-responders. This informative resource will be of value to neurologists, neurology trainees and ophthalmologists caring for patients with this rare disease, as well as patients with MG who wish to have a deeper dialog with their doctor or patient group. Contents: • Definition and epidemiology • Pathophysiology and classification • Diagnosis and management: an overview • Assessment of disease severity and treatment response Palace, Jacqueline A. Verfasser aut Erscheint auch als Druck-Ausgabe 978-1-910797-53-2 https://doi.org/10.1159/isbn.978-1-910797-54-9 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Silvestri, Nicholas J. Palace, Jacqueline A. Recognizing Refractory Myasthenia Gravis |
| title | Recognizing Refractory Myasthenia Gravis |
| title_auth | Recognizing Refractory Myasthenia Gravis |
| title_exact_search | Recognizing Refractory Myasthenia Gravis |
| title_exact_search_txtP | Recognizing Refractory Myasthenia Gravis |
| title_full | Recognizing Refractory Myasthenia Gravis Nicholas J. Silvestri, Jacqueline A. Palace |
| title_fullStr | Recognizing Refractory Myasthenia Gravis Nicholas J. Silvestri, Jacqueline A. Palace |
| title_full_unstemmed | Recognizing Refractory Myasthenia Gravis Nicholas J. Silvestri, Jacqueline A. Palace |
| title_short | Recognizing Refractory Myasthenia Gravis |
| title_sort | recognizing refractory myasthenia gravis |
| url | https://doi.org/10.1159/isbn.978-1-910797-54-9 |
| work_keys_str_mv | AT silvestrinicholasj recognizingrefractorymyastheniagravis AT palacejacquelinea recognizingrefractorymyastheniagravis |